Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.
View/ Open
Date
2017-05-01ICR Author
Author
Melin, BS
Barnholtz-Sloan, JS
Wrensch, MR
Johansen, C
Il'yasova, D
Kinnersley, B
Ostrom, QT
Labreche, K
Chen, Y
Armstrong, G
Liu, Y
Eckel-Passow, JE
Decker, PA
Labussière, M
Idbaih, A
Hoang-Xuan, K
Di Stefano, A-L
Mokhtari, K
Delattre, J-Y
Broderick, P
Galan, P
Gousias, K
Schramm, J
Schoemaker, MJ
Fleming, SJ
Herms, S
Heilmann, S
Nöthen, MM
Wichmann, H-E
Schreiber, S
Swerdlow, A
Lathrop, M
Simon, M
Sanson, M
Andersson, U
Rajaraman, P
Chanock, S
Linet, M
Wang, Z
Yeager, M
GliomaScan Consortium,
Wiencke, JK
Hansen, H
McCoy, L
Rice, T
Kosel, ML
Sicotte, H
Amos, CI
Bernstein, JL
Davis, F
Lachance, D
Lau, C
Merrell, RT
Shildkraut, J
Ali-Osman, F
Sadetzki, S
Scheurer, M
Shete, S
Lai, RK
Claus, EB
Olson, SH
Jenkins, RB
Houlston, RS
Bondy, ML
Type
Journal Article
Metadata
Show full item recordAbstract
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, but individual studies have had limited power to identify risk loci. We performed a meta-analysis of existing GWAS and two new GWAS, which totaled 12,496 cases and 18,190 controls. We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10-9, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10-10, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10-8, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10-11, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10-10, OR = 1.15), as well as eight loci for non-GBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10-9, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10-10, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10-10, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10-9, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10-8, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10-10, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10-11, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10-9, OR = 1.18). These data substantiate that genetic susceptibility to GBM and non-GBM tumors are highly distinct, which likely reflects different etiology.
Collections
Subject
GliomaScan Consortium
Humans
Glioma
Glioblastoma
Brain Neoplasms
Genetic Predisposition to Disease
Gene Expression Regulation, Neoplastic
Genotype
Polymorphism, Single Nucleotide
Alleles
Quantitative Trait Loci
Meta-Analysis as Topic
Genome-Wide Association Study
Research team
Aetiological Epidemiology
Cancer Genomics
Language
eng
Date accepted
2017-03-01
License start date
2017-05
Citation
Nature genetics, 2017, 49 (5), pp. 789 - 794
Publisher
NATURE PORTFOLIO